Loading…
Getting the latest data.
Bridgebio Pharma, Inc. 1.75%, Due 03/01/2031 3.7%Merit Medical Systems, Inc. 3%, Due 02/01/2029 3.1%Mirion Technologies, Inc. 0.25%, Due 06/01/2030 3.1%Uber Technologies, Inc. 0.875%, Due 12/01/2028 3.0%
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.5% | −5.2% | −5.5% | −10.3% | — | — | — | — | — | +1.5% |
| Peer average | +0.4% | +0.7% | +0.2% | −0.8% | −0.4% | +0.2% | +15.8% | +2.9% | +21.0% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$37 of every $1,000 in MCVT is Bridgebio
| # | |||||
|---|---|---|---|---|---|
| 1 | —Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.71% | $370.54 | 650K | $1.1M |
| 2 | —Merit Medical Systems, 3%, Due 02/01/2029 | 3.07% | $307.10 | 800K | $918K |
| 3 | —Mirion Technologies, 0.25%, Due 06/01/2030 | 3.06% | $305.95 | 900K | $915K |
| 4 | —Uber Technologies, 0.875%, Due 12/01/2028 | 2.98% | $298.20 | 800K | $892K |
| 5 | —Ormat Technologies, 2.5%, Due 07/15/2027 | 2.93% | $293.04 | 800K | $876K |
| 6 | —TransMedics Group, 1.5%, Due 06/01/2028 | 2.92% | $292.40 | 700K | $874K |
| 7 | —Nova 0%, Due 09/15/2030 | 2.77% | $277.03 | 700K | $828K |
| 8 | —Dropbox, 0%, Due 03/01/2028 | 2.75% | $274.71 | 750K | $821K |
| 9 | —Etsy, 1%, Due 06/15/2030 | 2.72% | $271.68 | 700K | $812K |
| 10 | —Haemonetics 2.5%, Due 06/01/2029 | 2.65% | $265.03 | 650K | $792K |
| 11 | —Granite Construction, 3.25%, Due 06/15/2030 | 2.65% | $264.94 | 500K | $792K |
| 12 | —HAT I, LLC / HAT II, LLC 3.75%, Due 08/15/2028 | 2.65% | $264.55 | 550K | $791K |
| 13 | —Tetra Tech, 2.25%, Due 08/15/2028 | 2.64% | $264.03 | 700K | $789K |
| 14 | —Itron, 0%, Due 03/15/2032 | 2.61% | $261.42 | 800K | $782K |
| 15 | —Bloom Energy 0%, Due 11/15/2030 | 2.58% | $258.27 | 650K | $772K |
Not enough history yet: MCVT needs a year of prices.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 21, 2026 | $0.0236 |
| Jun 15, 2026 | Jun 22, 2026 | $0.0075 |
of the $594B in 91 Core aggregate ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | — | Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.71% |
| 2 | — | Merit Medical Systems, 3%, Due 02/01/2029 | 3.07% |
| 3 | — | Mirion Technologies, 0.25%, Due 06/01/2030 | 3.06% |
| 4 | — | Uber Technologies, 0.875%, Due 12/01/2028 | 2.98% |
| 5 | — | Ormat Technologies, 2.5%, Due 07/15/2027 | 2.93% |
| 6 | — | TransMedics Group, 1.5%, Due 06/01/2028 | 2.92% |
| 7 | — | Nova 0%, Due 09/15/2030 | 2.77% |
| 8 | — | Dropbox, 0%, Due 03/01/2028 | 2.75% |
| 9 | — | Etsy, 1%, Due 06/15/2030 | 2.72% |
| 10 | — | Haemonetics 2.5%, Due 06/01/2029 | 2.65% |